這段影片將探討化療對癌症病患的效果,並根據實證醫學提供答案。儘管化療在癌症治療中廣泛使用,但其效果和副作用常引起討論和質疑。我們將分析科學研究和臨床試驗的數據,了解化療在不同癌症類型和階段中的效果,以及如何平衡其風險與益處。希望通過這些資訊,幫助觀眾更好地理解化療在癌症治療中的角色。 This video will explore the effectiveness of chemotherapy for cancer patients, providing answers based on evidence-based medicine. Although chemotherapy is widely used in cancer treatment, its efficacy and side effects are often debated and questioned. We will analyze scientific research and clinical trial data to understand the effectiveness of chemotherapy in different types and stages of cancer, as well as how to balance its risks and benefits. Through this information, we aim to help viewers better understand the role of chemotherapy in cancer treatment.
這段影片將解釋為什麼五年存活率在癌症治療中如此重要,以及它是否意味著五年後病患就能高枕無憂。我們將探討五年存活率的定義、它在預測病患預後中的作用,以及為什麼這個指標不能完全保證病患的長期健康。希望通過這些資訊,幫助觀眾更好地理解五年存活率的意義,並保持長期的健康監測和管理。 This video will explain why the five-year survival rate is so important in cancer treatment and whether it truly means that patients are safe after five years. We will explore the definition of the five-year survival rate, its role in predicting patient outcomes, and why this metric doesn't fully guarantee long-term health. Through this information, we aim to help viewers better understand the significance of the five-year survival rate and the importance of ongoing health monitoring and management.
手術後癌症復發的原因及輔助治療的必要性Reasons for Cancer Recurrence After Surgery and the Necessity of Adjuvant Therapy
許多癌症患者在接受手術治療後,仍有可能出現癌症復發的情況。本影片將探討手術後癌症復發的原因,包括殘留癌細胞和微轉移等因素,以及為何需要進行輔助治療,例如化療或放射治療,以減少復發的風險。 Many cancer patients may experience cancer recurrence even after undergoing surgery. This video will explore the reasons for cancer recurrence after surgery, including residual cancer cells and micrometastases, and why adjuvant therapy such as chemotherapy or radiation therapy is necessary to reduce the risk of recurrence.
這段影片將帶大家了解為何腹膜轉移在癌症治療中面臨重重困難。腹膜轉移的癌細胞容易擴散至腹腔各處,且血流與藥物難以集中於特定部位,使得治療效果受限。腫瘤科醫師將分享腹膜轉移的特性、治療挑戰,以及目前的治療方法和研究方向,幫助大家更清楚了解此種癌症轉移的嚴峻性和治療策略。 This video explores why peritoneal metastasis poses significant challenges in cancer treatment. Cancer cells in peritoneal metastasis easily spread throughout the abdominal cavity, with limited blood flow and drug concentration in specific areas, affecting treatment efficacy. An oncologist explains the characteristics of peritoneal metastasis, treatment challenges, and current therapeutic approaches and research directions, providing a deeper understanding of this complex cancer progression and management strategies.
你知道嗎?膽管癌不是每個人都能一發現就開刀,甚至很多人在診斷時已經喪失手術機會。 但你知道「化療+免疫治療」有機會讓原本不能開刀的病患轉變為可手術對象嗎? 在這支影片中,腫瘤科吳教恩醫師邀請林口長庚教授級主治醫師、外科專家李兆偉醫師,一起深入探討: 膽管癌的分型:肝內、肝門、總膽管與膽囊癌有何不同? 為什麼膽管癌這麼難發現?又有哪些危險因子要注意? 哪些情況能手術?「養肝」的原理是什麼? 微創 vs 達文西手術的優缺點比較 為什麼明明術前說可以開,卻手術中臨時喊停? 手術之後還要不要化療或免疫治療? 真實案例分享:化療+免疫治療半年後轉為可手術,術後成功出院 📌 本集重點內容: 膽管癌三大類型與腫瘤指數判讀 「養肝手術」是什麼?手術前如何擴增剩餘肝臟體積 化療+免疫治療的角色與最新健保給付 外科與腫瘤科協同合作的真實臨床對話 術前 vs 術中落差怎麼處理?為何開刀開不下去 膽管癌的術後追蹤、輔助性治療與存活率分析 💬 觀眾互動邀請: 你或你的親友曾被診斷為膽管癌嗎?曾經面臨「能不能開刀」的兩難抉擇嗎? 歡迎在留言區分享你的經驗與疑問,讓更多病友看見希望與可能。 👉 喜歡這支影片,請按👍讚、📢分享,並記得📌訂閱頻道與🔔開啟小鈴鐺,我們會持續帶來癌症治療的第一線知識與實證分析!
🎉 2025 年 2 月健保擴大給付!免疫治療和 ADC 的最新補助終於來了,癌症患者的負擔將大幅減少!這支影片將解析 健保最新補助範圍、哪些癌症能申請、如何申請 & 醫師的實際建議,幫助大家了解最新政策! 📌 本集內容重點: ✅ 哪些癌症符合健保給付?(肝癌、肺癌、膽管癌) ✅ 健保擴大補助的免疫治療藥物有哪些? ✅ 雙免疫治療 vs. 化療 + 免疫:如何選擇? ✅ 申請健保補助的條件 & 需要準備哪些資料? ✅ 未來可能擴大的補助範圍有哪些? 📢 如果這支影片對你有幫助,請記得按讚👍、訂閱🔔,並分享給需要的朋友! 🔍 更多癌症治療資訊,請觀看我們的相關影片!👇 #癌症 #癌症治療 #健保給付 #免疫治療 #癌症免疫藥物 #雙免疫治療 #標靶治療 #ADC治療 #癌症健保補助 #癌症最新政策 ❤️成為這個頻道的會員並獲得福利: https://www.youtube.com/channel/UCBvUlnJq3TpnGtbV6fdnl2A/join ❤️臉書粉專: https://m.facebook.com/profile.php/?id=100063644122566 ❤️IG: https://instagram.com/chiaoenpeter?igshid=OGQ5ZDc2ODk2ZA== 2025年2月,台灣健保進一步擴大癌症治療的給付範圍,新增多項免疫治療和抗體藥物偶聯物(ADC)的適應症,讓癌症病友在治療上減輕經濟負擔並與國際接軌。 新增健保給付項目 肝癌雙免疫治療:引入最新雙免疫組合,大幅提升晚期肝癌患者的治療成效。 小細胞肺癌:新增第二種免疫藥物適應症,適用於擴散期但無腦轉移的病患。 膽管癌:首次給付免疫治療與化療聯合用藥,提供患者新的治療選擇。 臨床意義 提升癌症控制率與病患存活率。 減輕患者的自費負擔,實現平等醫療。 申請條件 病患需通過健保審查,包含良好的生理狀況及肝腎功能等條件。 需提供完整的病歷與檢查資料進行申請。 展望未來 希望健保進一步涵蓋早期癌症治療,使患者有更高機率獲得治癒,降低疾病進展至晚期的機會。 In February 2025, Taiwan’s National Health Insurance expanded coverage for immunotherapy and antibody-drug conjugates (ADC) treatments, providing greater accessibility to advanced cancer therapies. Newly Covered Therapies Dual Immunotherapy for Liver Cancer: Enhanced survival rates for late-stage liver cancer patients. Small Cell Lung Cancer: Added coverage for a second immunotherapy drug for extensive-stage disease without brain metastases. Cholangiocarcinoma (Bile Duct Cancer): First-time coverage of immunotherapy combined with chemotherapy. Clinical Impact Improved cancer control and survival outcomes. Reduced financial burden for cancer patients, promoting equitable healthcare access. Eligibility Criteria Patients must meet stringent health requirements, including adequate organ function. Applications require comprehensive medical documentation and approval from health authorities. Future Outlook Advocating for insurance coverage in early-stage cancer treatments to increase cure rates and prevent disease progression.
這段影片將探討CEA(癌胚抗原)水平上升是否代表罹患癌症。雖然CEA是多種癌症的腫瘤標誌物,包括肺癌、大腸癌和胃癌,但其上升並不一定意味著癌症的存在。我們將分析CEA上升的可能原因,包括非癌症因素,以及如何在臨床上正確解讀CEA指數,幫助觀眾理解CEA的真正意義,避免不必要的恐慌。 This video will explore whether an elevated CEA (Carcinoembryonic Antigen) level means you have cancer. While CEA is a tumor marker for various cancers, including lung, colorectal, and stomach cancer, an increase in CEA levels doesn't necessarily indicate the presence of cancer. We will discuss other potential causes of elevated CEA, including non-cancerous factors, and how to interpret CEA levels correctly in a clinical setting to help viewers understand the true significance of CEA and avoid unnecessary panic.
膽管癌被稱為「隱形的癌王」,因為它的早期症狀通常難以察覺。本影片將深入探討膽管癌的早期警覺症狀,如黃疸、腹痛、皮膚瘙癢和體重減輕,幫助大家在日常生活中提高對這些徵兆的敏感度。及早發現這些症狀對於提高治療效果非常關鍵,請不要忽視這些微小變化。 Bile duct cancer, often referred to as the "silent killer," presents subtle symptoms in its early stages. In this video, we will explore the early warning signs of bile duct cancer, such as jaundice, abdominal pain, itching, and unexplained weight loss. Recognizing these symptoms early can be crucial in improving treatment outcomes. Pay attention to these small changes in your body for timely medical attention.
在這支影片中,腫瘤科吳教恩醫師邀請外科專家李醫師,一起解析膽管癌的治療評估與臨床挑戰。 為什麼有些病人明明影像看起來可以開刀,開進去卻無法切除? 什麼是術前評估看不到的腹膜轉移、血管侵犯? 為什麼外科與內科的合作,對於晚期膽管癌特別重要? 你將學到: 術前影像檢查的極限與盲點 腹腔鏡探查手術的意義與目的 化療+免疫治療如何幫助病患進入「可手術」狀態 外科手術不是單打獨鬥,內科藥物是關鍵夥伴 真正有機會治癒的策略:跨科合作、個別化治療規劃 📌 本集重點內容: 典型案例:年長病患健康檢查發現肝內膽管癌,手術評估過程 術前影像看不到的轉移與血管侵犯 腹腔鏡探查:開刀前最後的確認步驟 為什麼有些情況外科選擇放棄開刀,改走藥物治療 過去沒有藥物時代的外科與現在的不同 為什麼膽管癌與胰臟癌都需要外科與內科聯手治療 你或家人有膽管癌或胰臟癌的經驗嗎? 你曾經好奇過外科醫師怎麼評估能不能開刀嗎? 歡迎留言分享你的故事或疑問,我們會在未來影片中繼續討論這些重要議題!
膽管癌 被稱為「隱形癌王」,過去治療選擇有限,但近年來 免疫治療、標靶治療 為患者帶來了新的希望!這支影片將解析 膽管癌最新的標準治療、化療+免疫的成效、標靶藥物選擇與未來治療趨勢,幫助患者與家屬更了解如何提升治療效果! 📌 本集內容重點: ✅ 膽管癌為什麼難治? 存活率低的原因與治療挑戰 ✅ 第一線標準治療:化療+免疫治療如何提升存活率? ✅ 日本治療策略 vs. 國際標準:S-1 vs. 免疫治療 ✅ 第二線標靶治療選擇:FGFR2、IDH1、HER2、BRAF 突變治療 ✅ 基因檢測的重要性:如何選擇最適合的藥物? ✅ 未來展望:膽管癌還有哪些新藥物正在研究? 📢 如果這支影片對你有幫助,請記得按讚👍、訂閱🔔,並分享給需要的朋友! 🔍 更多癌症治療資訊,請觀看我們的相關影片!👇 #膽管癌 #癌症治療 #膽管癌治療 #標靶治療 #免疫治療 #膽管癌標靶藥物 #化療 #癌症研究 #癌症存活率 #癌症臨床試驗 ❤️成為這個頻道的會員並獲得福利: https://www.youtube.com/channel/UCBvUlnJq3TpnGtbV6fdnl2A/join ❤️臉書粉專: https://m.facebook.com/profile.php/?id=100063644122566 ❤️IG: https://instagram.com/chiaoenpeter?igshid=OGQ5ZDc2ODk2ZA== 膽管癌一直被稱為「隱形癌王」,因為它的發現往往已經是晚期,治療選擇有限。然而,隨著免疫治療與標靶藥物的發展,晚期膽管癌的治療有了新的突破。本影片將介紹膽管癌的最新治療策略,包括化療、免疫治療、標靶治療,以及健保於2025年2月起的新給付政策。此外,我們也會討論日本與國際治療趨勢的比較,帶您了解未來可能的治療方向。 Cholangiocarcinoma, often referred to as the "silent cancer king," is usually diagnosed at an advanced stage with limited treatment options. However, recent advancements in immunotherapy and targeted therapies have provided new hope for patients. This video covers the latest treatment strategies, including chemotherapy, immunotherapy, and targeted therapy, as well as Taiwan’s new reimbursement policy starting in February 2025. We also compare treatment approaches between Japan and international guidelines to explore potential future therapies.
這段影片將介紹腫瘤科醫師的工作內容,包括低劑量電腦斷層(LDCT)篩檢的應用與個人經驗。此外,影片將深入探討常規治療如化療、放療、手術,與新興的抗癌療法如免疫療法和標靶治療,及其在癌症治療中的重要性。隨著外泌體技術的發展,化療的作用是否減弱?營養與飲食對於抗癌的影響又是如何?本影片還將探討癌症疫苗、免疫治療的臨床進展及其對未來癌症預防的可能性,並探討如何預測免疫治療的效果及中醫在抗癌療程中的輔助作用。 This video introduces the role of oncologists, highlighting the application of Low-Dose CT (LDCT) screening and personal experiences. We will explore traditional cancer treatments such as chemotherapy, radiotherapy, and surgery, alongside emerging therapies like immunotherapy and targeted therapy. As exosome technology advances, does chemotherapy still play a key role? The impact of nutrition and diet in cancer treatment will also be discussed. Additionally, the video examines the latest clinical advancements in cancer vaccines and immunotherapy, their potential for cancer prevention, and tools for predicting immunotherapy outcomes, while also exploring the role of traditional Chinese medicine in cancer care.
這段影片深入探討了膽道癌治療的關鍵方面。從早期篩檢到先進的治療方法,影片涵蓋了膽道癌的診斷、手術、和藥物療法。著重介紹了新興的免疫療法和標靶治療。
本影片將探討「迴光返照」這個常見於病患臨終前的現象,分析其在臨床上的真實性與醫學解釋。我們將分享一些真實的臨床案例,並討論醫療團隊如何評估這樣的情況,以及它對病患家屬的心理影響。此現象到底是病情好轉的跡象,還是身體即將衰竭的表現?透過影片,我們將揭示這一現象背後的醫學理解。 This video explores the phenomenon known as "terminal lucidity," often observed in patients nearing the end of life. We'll analyze its clinical reality and medical explanations, sharing real-life case studies. The video will also discuss how medical teams assess such occurrences and its emotional impact on the patient's family. Is this phenomenon a sign of recovery, or an indication of impending deterioration? Join us as we delve into the medical insights behind this intriguing phenomenon.
這段影片將分享由日劇《命運交會》中的情節啟發,介紹膽囊癌的原因及最新治療方法。觀眾將了解膽囊癌的常見原因,如膽結石,並探討如何進行診斷和治療,包括手術、化療、放療和免疫治療等選項。 【膽囊癌, 原因, 治療方法, 日劇啟發, 膽結石, 診斷, 手術, 化療, 放療, 免疫治療】 This video, inspired by the Japanese drama 'Destiny's Intersection,' will discuss the causes and latest treatments of gallbladder cancer. Viewers will learn about common causes, such as gallstones, and explore diagnostic and treatment options, including surgery, chemotherapy, radiation therapy, and immunotherapy. 【gallbladder cancer, causes, treatments, Japanese drama inspiration, gallstones, diagnosis, surgery, chemotherapy, radiation therapy, immunotherapy】 🙋♂️請追蹤腫瘤科醫師的生活點滴🙋♂️ 💝臉書facebook: https://m.facebook.com/profile.php/?id=100063644122566 💝Instagram: https://instagram.com/chiaoenpeter?igshid=OGQ5ZDc2ODk2ZA== 💝加入頻道會員: https://www.youtube.com/channel/UCBvUlnJq3TpnGtbV6fdnl2A/join 💝分享會員專屬影片: https://www.youtube.com/playlist?list=UUMOBvUlnJq3TpnGtbV6fdnl2A
❤️成為這個頻道的會員並獲得福利: https://www.youtube.com/channel/UCBvUlnJq3TpnGtbV6fdnl2A/join ❤️臉書粉專: https://m.facebook.com/profile.php/?id=100063644122566 ❤️IG: https://instagram.com/chiaoenpeter?igshid=OGQ5ZDc2ODk2ZA== 飲用咖啡與茶是否影響膽管癌的發生風險?近期研究針對膽囊癌、肝內膽管癌等4大類膽管癌,進行了大型數據分析,揭示了飲品習慣與癌症風險的關聯性。 本影片將探討: 膽管癌簡介與分類:肝內、肝外膽管癌、膽囊癌及胡腹癌的不同特徵。 最新研究結果: 喝茶降低膽囊癌與肝內膽管癌風險的證據。 喝咖啡增加膽囊癌風險的觀察。 生活習慣與癌症風險:喝3杯以上咖啡或茶的背後因素分析。 研究限制與未來展望:更多關於咖啡與茶的品種、人種差異及生活習慣對健康影響的探討。 本影片將提供最新的科學洞見,幫助您在日常飲食選擇中做出更健康的決策。 Does coffee and tea consumption influence the risk of cholangiocarcinoma? A recent large-scale study investigated the association between beverage habits and the risk of four major types of bile duct cancer: gallbladder cancer, intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and ampullary carcinoma. This video covers: Introduction to bile duct cancer: Understanding the key differences among the four types. Key findings: Tea consumption reduces the risk of gallbladder and intrahepatic bile duct cancer. Coffee consumption increases the risk of gallbladder cancer. Lifestyle and cancer risks: Insights into the factors behind consuming more than three cups daily. Study limitations and future directions: Exploring variations in beverage types, ethnic differences, and lifestyle habits. Learn about the latest scientific insights and how they can help guide your daily beverage choices for better health outcomes.
本影片將分享一個透過臨床判斷與病理診斷的深入合作,成功推翻初步診斷,並為病患帶來更佳治療結果的真實案例。我們將探討醫療團隊如何在初步診斷中發現疑點,並依靠病理科的詳細檢驗來修正診斷,從而選擇更適合的治療方式,幫助病患獲得最佳的醫療結果。這強調了臨床醫師與病理科合作的重要性,並展示了精確診斷對治療效果的關鍵影響。 This video presents a real case study where collaboration between clinical judgment and pathological diagnosis successfully overturned an initial diagnosis, leading to a more effective treatment plan for the patient. We will explore how the medical team identified discrepancies in the initial diagnosis and relied on detailed pathological analysis to adjust the diagnosis, allowing for more appropriate treatment options. This case highlights the importance of collaboration between clinicians and pathologists, emphasizing the crucial impact of accurate diagnosis on treatment outcomes.
在這集影片中,腫瘤科吳教恩醫師與一般外科名醫李兆偉醫師,深入聊聊大眾常搞不清楚的「一般外科」。從肝膽胰手術到膽管癌、肝癌、胰臟癌,外科醫師怎麼評估能不能開刀?為什麼有些病人腫瘤縮小後還要先「養肝」?微創手術、腹腔鏡、達文西手術又有什麼差別? 本集將帶你了解: ✅ 一般外科的工作範圍有哪些? ✅ 哪些膽管癌患者有機會接受手術? ✅ 微創與達文西手術的優勢與健保給付重點 ✅ 化療、免疫治療與外科合作的新趨勢 ✅ 癌症手術後為什麼還要持續追蹤? 不論你是醫療關注者、癌症病友或家屬,都能從中獲得寶貴的醫療知識。 記得按讚、訂閱、開啟小鈴鐺,分享給需要的朋友!
原發性肝癌通常起源於肝細胞,而肝膽管癌則涉及肝臟和膽管系統。轉移性肝腫瘤則是其他部位腫瘤轉移到肝臟形成的次要腫瘤。透過本影片,您將學到這些肝腫瘤的區別關鍵點,以及在臨床實踐中如何確定和處理它們。 Primary hepatocellular carcinoma originates from liver cells, while cholangiocarcinoma involves the liver and bile duct system. Metastatic liver tumors result from the spread of tumors from other parts of the body to the liver. This video will provide insights into the distinguishing features of these liver tumors, along with clinical presentations and diagnostic approaches, empowering viewers to better comprehend and differentiate between these distinct liver pathologies.
診斷癌症的名偵探:病理科醫師與臨床醫師的合作Cancer Diagnosis Detectives: Collaboration Between Pathologists and Clinicians
診斷癌症如同一場破案,病理科醫師與臨床醫師是這場探案中的兩大主角。他們密切合作,通過精確的病理診斷,為患者提供正確的治療策略。本影片將介紹病理科醫師在癌症診斷中的角色,並探討他們如何與臨床醫師合作,為每位癌症病患設計最適合的治療方案。 Diagnosing cancer is like solving a mystery, with pathologists and clinicians working together as the lead detectives. Through accurate pathology diagnosis, they ensure the right treatment strategies are applied. This video will explain the crucial role of pathologists in cancer diagnosis and explore how they collaborate with clinicians to tailor the best treatment plans for each cancer patient.
隨著外泌體等新興抗癌技術的出現,化療是否仍然在癌症治療中扮演重要角色?本影片將探討化療在現代癌症治療中的作用,外泌體技術的潛力,以及營養與飲食對於抗癌的重要性,幫助病患更好地面對治療挑戰。 With the rise of cutting-edge cancer technologies like exosomes, does chemotherapy still play a significant role in cancer treatment? This video will explore the current role of chemotherapy, the potential of exosome technology, and the critical importance of nutrition and diet in supporting cancer patients through their treatment journey.








![[隱形的癌王] 膽管癌的早期警覺症狀 [Silent Killer] Early Warning Signs of Bile Duct Cancer](https://image1-us-west.cloudokyo.cloud/image/v3/24/7d/33/247d33e9-e8ad-4d92-82f5-4095ceae66a8/672.webp)











